NCT00133276View on ClinicalTrials.gov

Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2009

Conditions
Hepatitis C
Interventions
DRUG

Escitalopram

OD 5mg for 2 weeks; OD 10mg for 24 weeks; OD 5mg for 2 weeks

OTHER

Placebo

Trial Locations (3)

3015GD

Erasmus MC University Hospital, Rotterdam

1100DD

AMC, Amsterdam

6500 HB

Radboud University Hospital, Nijmegen

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER